The global cancer biomarkers market, valued at USD 15.80 billion in 2024, is anticipated to grow at a CAGR of 14.30% during 2025–2034, reaching USD 60.13 billion by 2034, driven by rising cancer prevalence, advances in precision medicine, and growing demand for early diagnosis solutions. https://www.expertmarketresearch.com/reports/cancer-biomarkers-market